https://www.bioworld.com/rss en-us http://www.bioworld.com/articles/731353 Mon, 18 May 2026 13:00:00 -0400 https://www.bioworld.com/articles/731353-money-raised-by-biopharma http://www.bioworld.com/articles/731315 Mon, 18 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/731315-med-tech-m-and-as-blockbuster-streak-continues-with-19b-april-value Handshake with dollar sign and checkmark http://www.bioworld.com/articles/731313 Mon, 18 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/731313-sen-cassidys-primary-loss-increases-uncertainty Health care and politics illustration http://www.bioworld.com/articles/731311 Mon, 18 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/731311-bundibugyo-is-harsh-reminder-of-need-for-broad-vaccine-strategies Virus and vaccine illustration http://www.bioworld.com/articles/731318 Mon, 18 May 2026 11:00:00 -0400 https://www.bioworld.com/articles/731318-biggest-gainers-and-losers-for-may-11-15-2026 http://www.bioworld.com/articles/731212 Fri, 15 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/731212-biopharma-deal-and-m-and-a-values-soar-in-early-2026 DNA with bar chart http://www.bioworld.com/articles/731197 Thu, 14 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/731197-uspto-doubles-down-on-inconsistencies-in-dual-ipr-court-action Patent gears Nature that delved into mechanisms that rev up the NLRP3 inflammasome.]]> http://www.bioworld.com/articles/731061 Wed, 13 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/731061-in-the-mix-post-ventyx-more-nlrp3s-to-seize NLRP3 inflammasome http://www.bioworld.com/articles/731060 Wed, 13 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/731060-life-sciences-sweet-opportunity-in-us-china-talks China and U.S. flags http://www.bioworld.com/articles/731229 Tue, 12 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/731229-kaileras-record-ipo-headlines-strong-april-for-biopharma-financings Financial markets rebound illustration http://www.bioworld.com/articles/731228 Tue, 12 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/731228-follow-ons-hit-7-year-high-lead-med-techs-10b-start-to-2026 Dollar sign thermometer http://www.bioworld.com/articles/731038 Mon, 11 May 2026 11:00:00 -0400 https://www.bioworld.com/articles/731038-biggest-gainers-and-losers-for-may-4-8-2026 http://www.bioworld.com/articles/731099 Fri, 08 May 2026 13:00:00 -0400 https://www.bioworld.com/articles/731099-bioworld-and-nasdaq-stock-indices http://www.bioworld.com/articles/731094 Fri, 08 May 2026 13:00:00 -0400 https://www.bioworld.com/articles/731094-biopharma-money-raised-jan-1-may-7-2026 http://www.bioworld.com/articles/731093 Fri, 08 May 2026 13:00:00 -0400 https://www.bioworld.com/articles/731093-money-raised-by-biopharma http://www.bioworld.com/articles/731098 Fri, 08 May 2026 12:25:00 -0400 https://www.bioworld.com/articles/731098-biopharma-money-raised-by-month-in-2026-usm http://www.bioworld.com/articles/730985 Fri, 08 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730985-follow-ons-hit-7-year-high-lead-med-techs-10b-start-to-2026 Dollar sign thermometer http://www.bioworld.com/articles/730979 Fri, 08 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730979-budo-judo-moves-aplenty-for-climb-in-autoimmune Illustration of antibodies attacking nerve cells MV Hondius, the ship currently heading to the Canary Islands with its remaining passengers plus assorted medical, WHO and European Center for Disease Prevention and Control staff, is the 2026 version of the Diamond Princess.]]> http://www.bioworld.com/articles/731113 Fri, 08 May 2026 09:00:00 -0400 https://www.bioworld.com/articles/731113-hantavirus-is-sentinel-more-than-acute-pandemic-threat Close up of bow of cruise ship BioWorld Infectious Disease Index (BIDI), saw their collective shares roughly follow the path of broader markets like the Nasdaq Biotechnology Index (NBI) and the Dow Jones Industrial Average (DJIA) in early 2026. The BIDI ended April up 3.8%, followed by the DJIA with a 3.31% gain and 2.73% for the NBI, following a similar pattern to 2025.]]> http://www.bioworld.com/articles/730971 Thu, 07 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730971-moderna-vir-among-early-2026-top-infectious-disease-gainers Viruses MV Hondius, the ship currently heading to the Canary Islands with its remaining passengers plus assorted medical, WHO and European Center for Disease Prevention and Control staff, is the 2026 version of the Diamond Princess.]]> http://www.bioworld.com/articles/730969 Thu, 07 May 2026 07:00:00 -0400 https://www.bioworld.com/articles/730969-hantavirus-is-sentinel-more-than-acute-pandemic-threat Close up of bow of cruise ship http://www.bioworld.com/articles/730866 Wed, 06 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730866-kaileras-record-ipo-headlines-strong-april-for-biopharma-financings Financial markets rebound illustration http://www.bioworld.com/articles/730865 Wed, 06 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730865-swiss-biotech-reports-record-private-investment-employment-in-2025 Swiss currency http://www.bioworld.com/articles/730927 Tue, 05 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730927-bio-korea-2026-kicks-off-with-spotlight-on-oligonucleotides AI generated image for researcher developing antisense oligonucleotides http://www.bioworld.com/articles/730926 Tue, 05 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730926-bio-korea-2026-us-policy-risks-shift-to-execution-framework Strategy compass http://www.bioworld.com/articles/730835 Mon, 04 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730835-bio-korea-2026-us-policy-risks-shift-to-execution-framework Strategy compass http://www.bioworld.com/articles/730840 Mon, 04 May 2026 11:00:00 -0400 https://www.bioworld.com/articles/730840-biggest-gainers-and-losers-for-april-27-may-1-2026 http://www.bioworld.com/articles/730877 Fri, 01 May 2026 13:00:00 -0400 https://www.bioworld.com/articles/730877-biopharma-money-raised-jan-1-april-30-2026 http://www.bioworld.com/articles/730876 Fri, 01 May 2026 13:00:00 -0400 https://www.bioworld.com/articles/730876-money-raised-by-biopharma http://www.bioworld.com/articles/730753 Thu, 30 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730753-day-one-buyout-headlines-active-q1-for-cancer-stocks Financial graph